Category Archives: R&D

Patient Recruitment via Social Media: Lessons Learned

By Guest Blogger | Published: February 13, 2012
By Marylyn Donahue. All-told the Mayo Clinic’s recent pilot study on clinical trial patient recruitment using social media and online networks not only helped researchers assemble large and demographically diverse patient groups more quickly, but also less expensively than they could through other means. “This study is a prime example of patient-initiated research that could be used [...]
Also posted in social media | Tagged , , | 5 Comments

Witty Touts GSK Pipeline in 4th Quarter Review

By Reid Paul | Published: February 10, 2012
brightcove.createExperiences();
Also posted in Emerging Markets, Europe, Global, News, Strategy | Tagged , , , , , , | Leave a comment

Fighting Tropical Disease: It's Now a Common Cause

By Guest Blogger | Published: February 8, 2012
David Torstensson, Senior Consultant, Pugatch Consilium, considers what the London Declaration on Neglected Tropical Diseases reveals about research and development efforts into neglected and tropical diseases. Last week, the Gates Foundation, several government aid agencies, the World Health Organization [WHO], and a host of  biopharm companies including GSK, Merck, Eisai, J&J, Sanofi, Novartis, Bayer and Abbott, [...]
Also posted in Global, Guest Blog, healthcare | Tagged , , , | Leave a comment

Government-Funded Research: Is It That Different?

By Guest Blogger | Published: February 2, 2012
In December 2011, the President’s Bioethics Commission released its “Moral Science: Protecting Participants in Human Subjects Research.” The report was ordered by President Obama following an October 2010 revelation that the US Public Health Service supported unethical research in Guatemala from 1946 to 1948 that involved intentionally exposing thousands of Guatemalans to sexually transmitted diseases [...]
Also posted in Guest Blog, Regulatory, Safety | Tagged , , , | Leave a comment

JP Morgan Healthcare Conference Marked by Uncertainty

By Guest Blogger | Published: January 12, 2012
2012 J.P. Morgan Healthcare Conference Marked by Uncertainty Audrey S. Erbes, Principal, Erbes & Associates, outlines the highlights of this week’s event in San Francisco. One of the few positive notes struck in this week’s 30th Annual J.P. Morgan Healthcare Conference (held in San Francisco) was the announcement by Kevin Willsey, J.P. Morgan’s co-head of investment banking [...]
Also posted in Guest Blog, Strategy, healthcare | Tagged , , , , | 2 Comments